CA2566655C - Formulations pharmaceutiques utiles pour inhiber la secretion d'acides et procedes correspondants de fabrication et d'utilisation - Google Patents

Formulations pharmaceutiques utiles pour inhiber la secretion d'acides et procedes correspondants de fabrication et d'utilisation Download PDF

Info

Publication number
CA2566655C
CA2566655C CA2566655A CA2566655A CA2566655C CA 2566655 C CA2566655 C CA 2566655C CA 2566655 A CA2566655 A CA 2566655A CA 2566655 A CA2566655 A CA 2566655A CA 2566655 C CA2566655 C CA 2566655C
Authority
CA
Canada
Prior art keywords
pharmaceutical formulation
proton pump
meq
pump inhibitor
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2566655A
Other languages
English (en)
Other versions
CA2566655A1 (fr
Inventor
Kay Olmstead
Warren Hall
Gerald T. Proehl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santarus Inc
Original Assignee
Santarus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santarus Inc filed Critical Santarus Inc
Publication of CA2566655A1 publication Critical patent/CA2566655A1/fr
Application granted granted Critical
Publication of CA2566655C publication Critical patent/CA2566655C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2566655A 2004-05-25 2005-05-25 Formulations pharmaceutiques utiles pour inhiber la secretion d'acides et procedes correspondants de fabrication et d'utilisation Expired - Fee Related CA2566655C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US57464604P 2004-05-25 2004-05-25
US57466304P 2004-05-25 2004-05-25
US60/574,646 2004-05-25
US60/574,663 2004-05-25
PCT/US2005/018585 WO2005115474A1 (fr) 2004-05-25 2005-05-25 Formulations pharmaceutiques utiles pour inhiber la secretion d'acides et procedes correspondants de fabrication et d'utilisation

Publications (2)

Publication Number Publication Date
CA2566655A1 CA2566655A1 (fr) 2005-12-08
CA2566655C true CA2566655C (fr) 2013-04-16

Family

ID=35450661

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2566655A Expired - Fee Related CA2566655C (fr) 2004-05-25 2005-05-25 Formulations pharmaceutiques utiles pour inhiber la secretion d'acides et procedes correspondants de fabrication et d'utilisation

Country Status (5)

Country Link
EP (1) EP1750767A4 (fr)
JP (1) JP2008500365A (fr)
CA (1) CA2566655C (fr)
MX (1) MXPA06013585A (fr)
WO (1) WO2005115474A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2068841B1 (fr) * 2006-10-05 2018-09-26 Santarus, Inc. Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations
PE20140005A1 (es) * 2010-12-03 2014-01-23 Takeda Pharmaceutical Tableta oralmente desintegradora
JP6641626B2 (ja) * 2015-12-25 2020-02-05 エスエス製薬株式会社 制酸用医薬組成物
KR102080023B1 (ko) * 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102006777B1 (ko) * 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
MX2021001905A (es) * 2018-08-23 2021-04-28 Chong Kun Dang Pharmaceutical Corp Preparacion farmaceutica que tiene excelentes propiedades de disolucion, que contiene esomeprazol y bicarbonato de sodio.
BR112022001287A2 (pt) * 2019-07-26 2022-04-12 Chong Kun Dang Pharmaceutical Corp Composição farmacêutica
KR102573842B1 (ko) * 2020-02-21 2023-09-01 주식회사 종근당 방출특성이 우수한 에스오메프라졸 및 탄산수소나트륨의 약제학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5622719A (en) 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
EP2260837A1 (fr) * 2001-06-01 2010-12-15 Pozen, Inc. Compositions pharmaceutiques pour l'administration coordonnée d'AINS
US20050037070A1 (en) * 2003-07-18 2005-02-17 Santarus, Inc. Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them
EP1718303A4 (fr) * 2004-02-10 2010-09-01 Santarus Inc Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien
EP1742630A4 (fr) * 2004-04-16 2010-01-20 Santarus Inc Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique

Also Published As

Publication number Publication date
WO2005115474B1 (fr) 2006-02-23
MXPA06013585A (es) 2009-07-22
JP2008500365A (ja) 2008-01-10
EP1750767A1 (fr) 2007-02-14
CA2566655A1 (fr) 2005-12-08
WO2005115474A1 (fr) 2005-12-08
EP1750767A4 (fr) 2010-09-22

Similar Documents

Publication Publication Date Title
US20220133778A1 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005076987A2 (fr) Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien
US20050239845A1 (en) Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8993599B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531564C (fr) Formulations pharmaceutiques utilisees pour inhiber une secretion acide et procede de fabrication associe
US20050244517A1 (en) Combination of proton pump inhibitor and sleep aid
CA2566655C (fr) Formulations pharmaceutiques utiles pour inhiber la secretion d'acides et procedes correspondants de fabrication et d'utilisation
EP1603537A2 (fr) Liberation immediate d'un complexe antacide d'omeprazole presentant une nouvelle formulation pour une elimination rapide et prolongee d'acide gastrique
CA2579177A1 (fr) Nouvelle formulation de complexe antiacide d'omeprazole a liberation immediate pour inhibition rapide et prolongee de la production d'acide gastrique
US20070292498A1 (en) Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
AU2011265561B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2005331781B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion
MXPA06009036A (en) Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
AU2005204242A1 (en) A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
MXPA06005084A (en) Combination of proton pump inhibitor and sleep aid

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190527